Unique ID issued by UMIN | UMIN000040669 |
---|---|
Receipt number | R000046420 |
Scientific Title | Difference in clinical features between idiopathic and secondary chronic intestinal pseudo-obstruction:A retrospective single center study |
Date of disclosure of the study information | 2020/06/08 |
Last modified on | 2020/06/05 19:34:21 |
Difference in clinical features between idiopathic and secondary chronic intestinal pseudo-obstruction:A retrospective single center study
Difference in clinical features between idiopathic and secondary chronic intestinal pseudo-obstruction
Difference in clinical features between idiopathic and secondary chronic intestinal pseudo-obstruction:A retrospective single center study
Difference in clinical features between idiopathic and secondary chronic intestinal pseudo-obstruction
Japan |
Chronic Intestinal Pseudo-obstruction (CIPO)
Gastroenterology | Adult |
Others
NO
To compare the clinical characteristics and prognosis between idiopathic and secondary CIPO
Others
To find the effective therapy in each type and help establish the treatment strategy in patients with CIPO
Rate of intravenous hyperalimentation (IVH) requirement
Ratio of idiopathic and secondary CIPO
Underlying diseases in secondary CIPO
Age of onset
Cine-MRI findings
Nutritional status (serum albumin level, body mass index)
Effective rate of enteric sterilization
Prognosis (Mortality rate)
Observational
Not applicable |
Not applicable |
Male and Female
Patients who meet following 1-7 criteria (idiopathic CIPO) or 1-6 criteria (secondary CIPO) are eligible
Diagnostic criteria of CIPO
1. Persistent or recurrent symptoms of bowel obstruction such as abdominal bloating, nausea, vomiting, and pain
2. Disease duration of more than 2 months for newborn onset and 6 months for onset after infancy
3. Dilatation of gastrointestinal tract and air-fluid level on radiological images
4. No evidence of structural diseases
5. No morphological abnormalities in the plexus on HE staining of intestinal full-thickness biopsy
6. Exclusion of megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) and segmental dilatation of intestine for pediatric patients
7. Exclusion of secondary CIPO
1)Patients with current malignant diseases under treatment
(patients with stable condition and not requiring active treatment are allowed)
2)Patients with severe psychiatric diseases
(patients with stable condition are allowed)
50
1st name | Hidenori |
Middle name | |
Last name | Ohkubo |
Yokohama City University Hospital
Division of Hepatology and Gastroenterology
236-0004
3-9 Fukuura Kanazawa-ku Yokohama City
045-787-2800
ohkuboh@yokohama-cu.ac.jp
1st name | Hidenori |
Middle name | |
Last name | Ohkubo |
Yokohama City University Hospital
Division of Hepatology and Gastroenterology
236-0004
3-9 Fukuura Kanazawa-ku Yokohama City
045-787-2800
ohkuboh@yokohama-cu.ac.jp
Yokohama City University Hospital
Yokohama City University
Self funding
Yokohama City University Ethical Committee for Medical and Health Research Involving Human Subjects
5F Technocore Yokohama Kanazawa High-Tech Center 1-1-1 Fukuura, Kanazawa-ku, Yokohama City
045-370-7627
rinri@yokohama-cu.ac.jp
NO
2020 | Year | 06 | Month | 08 | Day |
Unpublished
Preinitiation
2020 | Year | 06 | Month | 01 | Day |
2020 | Year | 09 | Month | 01 | Day |
2020 | Year | 10 | Month | 31 | Day |
A single center retrospective study.
2020 | Year | 06 | Month | 05 | Day |
2020 | Year | 06 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046420
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |